Combining professional development with real world application.

A dedicated service team with deep experience and expertise .

Advisory Board


Prof. Dr. Till Opatz

Johannes Gutenberg-Universität Mainz

Department of Chemistry

Till Opatz studied chemistry at the University of Frankfurt/M. and finished his diploma with Johann Mulzer in 1997. In 2001, he obtained his Ph.D. for a thesis on combinatorial carbohydrate chemistry with Horst Kunz at the Johannes Gutenberg University Mainz. After a postdoc with Rob Liskamp in Utrecht/Netherlands on supramolecular chemistry and artificial receptors, he started his independent research (heterocyclic chemistry, method development) in Mainz in 2002, which led to his “habilitation” in 2006. In 2007, he became associate/full professor in Hamburg and then full professor at the Institute of Organic Chemistry in Mainz in 2010. His main research interests are heterocyclic chemistry, photochemistry, sustainable chemistry and the synthesis and structure elucidation of bioactive natural products.

Advisory Board


Thomas Ebeling

Bernd Miehler

Dr. Kemal Malik

Thomas Ebeling has studied psychology at the University of Hamburg.


After graduating, Ebeling started his career at Reemtsma, where he was responsible for the "West" brand as a product manager. In 1991 Ebeling joined Pepsi-Cola, Germany, where held various director positions in marketing and sales. In 1996 he was assigned to be the General Manager of Pepsi-Cola Germany.


In 1997 Ebeling joined Novartis as the General Manager of Novartis' Nutrition for Germany and Austria. Following, he took over the Global Management of the Nutrition Division and became a member of Novartis' Executive Board. In 2000 he became Novartis' Global Pharmaceutical Business Chief Executive Officer ("CEO") and in 2007 the CEO of the Novartis Consumer Health Division.


Between 2009 and 2018, Ebeling was the CEO of ProSiebenSat.1 Media. Since 2017 Ebeling has been a professional Non-Exec Board Member and advises a wide range of companies and owners. Besides, he has been a member of the Board of Directors of Lonza Group since April 2013.

Bernd Miehler studied business administration and process engineering at the University of Stuttgart and at the University of Massachusetts in Dartmouth, USA.


Previously, Miehler was the senior vice president program office and member of the group management at Jet Aviation AG in Switzerland, the global leader in business aviation. There he was responsible for corporate transformation and acquisition.


Miehler also worked as a senior manager at the leading international management consultancy A.T. Kearney in the areas of operations and M&A. He also worked on international projects in leading positions in Brazil and Germany.

From 2014 to 2020, Miehler was Executive Vice President at TeamViewer, leading Corporate Development. He was responsible for managing all internal workstreams of TeamViewers IPO, which was amongst the largest German tech IPOs. 

Dr. Kemal Malik holds a medical and a surgery degree from the University of London and the Faculty of Medicine at Imperial College London.


Dr. Malik has had an outstanding career through a variety of senior and C-level positions in the pharmaceutical industry, making him an experienced industry leader.


He held various positions in medical affairs and clinical development at Bristol-Myers Squibb in the UK. In 1995 he joined Bayer AG's Pharmaceuticals Business Group and was then named Head of Global Medical Development before being appointed Head of Global Development and Head of LEAPS. His area of responsibilities also covered the strategic venturing of Bayer, achieving groundbreaking innovations.


Between 2014 and 2019, Dr. Malik was a member of Bayer AG's Board of Management and was responsible for the Innovation Business of Bayer Group.

Jan Beckers

Nikita Fahrenholz

Jan Beckers has a diploma degree in business administration from the University of Münster


Beckers is one of the leading German serial entrepreneurs and investors, who started investing at the age of 16 and started building companies as early as 20. Beckers is the founder of companies such as Absolventa, Fyber, finleap, Heartbeat Labs, and IONIQ Group, invested in Delivery Hero in the early stages and invested in Facebook as well as Linkedin before the IPO. 


As Executive Chairman of the IONIQ Group, his responsibilities include strategy, investments, and strategic partnerships. Doubtless, Beckers has the instinct and determination for bold moves into uncharted territory. His success proves him right. In 2014, Beckers was awarded as "Entrepreneur of the Year" by Ernst & Young, Germany.

Nikita Fahrenholz holds a degree in business administration from the ESB Reutlingen and the Lancaster University. 


He is one of the most successful start-up entrepreneurs in Germany. After his studies, Fahrenholz joined McKinsey & Company as a consultant. With and Book A Tiger, he has built up two very well-known companies. 


In 2011, after founding, he initiated the merger with Delivery Hero and was a member of the global management team with responsibility for strategy and operations until 2014.


With co-founder Claude Ritter, he subsequently founded Book A Tiger – a platform solution to connect businesses and private customers with cleaning and additional household services. Fahrenholz was CEO here until 2018 and since 2018 Chairman of the Board. In 2019, he started another project: Fahrengold, a start-up that offers the “garages of the future”. Fahrenholz has received several awards. Among others, the Financial Times voted him number 2 of European Tech Entrepreneurs. 

Synbionik was founded in early 2019. Its headquarter is in Frankfurt/Main, Germany.